Regeron, Inc.
Records under this name other than patents Regeron, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Regeron, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,956,263 | Composition for improving skin conditions comprising a fragment of human heat shock protein 90A as an active ingredient Lapsed on the fee record Ended May 1, 2026 · From the USPTO record | Lapsed on the fee record | Ended May 1, 2026 | From the USPTO record |
| US 8,569,240 | Methods of Preventing or Treating Brain Diseases Lapsed on the fee record Ended Oct 29, 2025 · Medium confidence | Lapsed on the fee record | Ended Oct 29, 2025 | Medium confidence |
| US 10,822,382 | Composition for Improving Skin Conditions Comprising a Fragment of Human Heat Shock Protein 90A as an Active Ingredient Lapsed on the fee record Ended Nov 3, 2024 · Low confidence | Lapsed on the fee record | Ended Nov 3, 2024 | Low confidence |
| US 7,951,396 | Preparation of nanoliposome-encapsulating proteins and protein-encapsulated nanoliposome Lapsed on the fee record Ended May 31, 2023 · From the USPTO record | Lapsed on the fee record | Ended May 31, 2023 | From the USPTO record |
| US 9,598,475 | Methods of Preventing or Treating Brain Diseases Lapsed on the fee record Ended Mar 21, 2021 · Medium confidence | Lapsed on the fee record | Ended Mar 21, 2021 | Medium confidence |
| US 8,846,611 | Skin conditions using human growth hormone Lapsed on the fee record Ended Sep 30, 2018 · From the USPTO record | Lapsed on the fee record | Ended Sep 30, 2018 | From the USPTO record |